These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ethics and industry-sponsored research. Pater JL; Parulekar W; O'Callagham C; Shepherd L; Eisenhouer E; Seymour L; Tu D; Ding K CMAJ; 2002 Mar; 166(5):581-2. PubMed ID: 11898934 [No Abstract] [Full Text] [Related]
6. Between the lines: navigating the uncharted territory of industry-sponsored research. Davidoff F Health Aff (Millwood); 2002; 21(2):235-42. PubMed ID: 11900164 [No Abstract] [Full Text] [Related]
7. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research. Woo SL Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736 [No Abstract] [Full Text] [Related]
9. [Decisions made by the industry to stop trials--important to inform when and why it happens]. Bergqvist D Lakartidningen; 2000 Nov; 97(46):5367-8. PubMed ID: 11116876 [No Abstract] [Full Text] [Related]
10. Physicians and the pharmaceutical industry. Canadian Medical Association CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903 [No Abstract] [Full Text] [Related]
11. CMA guidelines on MD-drug industry relations part of international trend. Williams JR CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902 [No Abstract] [Full Text] [Related]
12. The benefits and risks of a pack of M&Ms. Spilker B Health Aff (Millwood); 2002; 21(2):243-4. PubMed ID: 11900165 [No Abstract] [Full Text] [Related]
13. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
14. The CMA's MD-drug industry guidelines offer advice, nothing more. Woollard R CMAJ; 1991 Dec; 145(11):1498-9. PubMed ID: 11649304 [No Abstract] [Full Text] [Related]
15. Physicians and the pharmaceutical industry (update 2001). Canadian Medical Association CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156 [No Abstract] [Full Text] [Related]
16. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more. Rapp MS; Woollard R CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303 [No Abstract] [Full Text] [Related]
17. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy? Ferris LE CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844 [No Abstract] [Full Text] [Related]
18. Two societies address financial conflicts of interest in gene therapy trials. Prof Ethics Rep; 2000; 13(2):6-7. PubMed ID: 11820249 [No Abstract] [Full Text] [Related]